Search results

Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":

Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual)...

All the templates and supporting documents you need to make a technology appraisals submission with NICE.

Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.

Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.

Result type

HealthTech guidance

Published

10 July 2019

Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease.

Result type

HealthTech guidance

Published

17 February 2016

Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the dose of 5-FU.

Result type

HealthTech guidance

Published

10 December 2014

Evidence-based recommendations on viscoelastometric point-of-care testing devices (the ROTEM, TEG and Sonoclot systems).

Result type

HealthTech guidance

Published

20 August 2014

Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic non-small-cell-lung cancer.

Result type

HealthTech guidance

Published

14 August 2013

Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care.

Result type

HealthTech guidance

Published

27 January 2022

Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders.

Result type

HealthTech guidance

Published

8 March 2021

Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury.

Result type

HealthTech guidance

Published

12 November 2014

Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta.

Result type

HealthTech guidance

Last updated

1 October 2018